Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment

This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.

Bibliografske podrobnosti
Glavni avtor:	Shaikat, Mahdi Mubin
Drugi avtorji:	Bin Naser, Dr. Iftekhar
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2023
Teme:	CRISPR/Cas9 Genome editing Cancer Vectors Onco genes Cancer treatment Gene editing > Technological innovations. Cancer > Treatment
Online dostop:	http://hdl.handle.net/10361/18984

Podobne knjige/članki

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
od: Maria, Amatul
Izdano: (2020)

A review on CRISPR-Cas system based applications in Oncology
od: Sadia, Mir
Izdano: (2022)

A review on CRISPR Technology as an Antiviral Tool
od: Srishti, Sanjida Ahmed
Izdano: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
od: Ullah, Mohammad
Izdano: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
od: Rahman, Samia
Izdano: (2022)

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
od: Eva, Israt Ara Jannat
Izdano: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Izdano: (2022)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
od: Islam, Ankita
Izdano: (2022)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Izdano: (2021)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Izdano: (2022)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Izdano: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Izdano: (2019)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Izdano: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
od: Hossain, Safa Binte
Izdano: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
od: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
od: Muntaha, Habibatul
Izdano: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
od: Rahman, Qazi Ashrafur
Izdano: (2018)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Izdano: (2024)

Oncogenes: new targets in cancer treatment
od: Chowdhury, Waseka Shams
Izdano: (2020)

Qualitative classification of the breast cancer genome and clustering of the cancer gene network
od: Fatema, Kaniz, et al.
Izdano: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Izdano: (2024)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Izdano: (2021)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Izdano: (2023)

Analysis and comparison between the Genome of CRISPR bacteriophages
od: Muntaha, Mumtasin
Izdano: (2021)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
od: Ahmed, Kazi Zeba
Izdano: (2021)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
od: Beruni, Sajid Mahmud Al
Izdano: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
od: Nwabunwanne, Eze Uchenna
Izdano: (2022)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Izdano: (2024)

A review on triple-negative breast cancer and its potential treatment
od: Niasa, Jannatul Ferdous
Izdano: (2023)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
od: Akter, Honufa
Izdano: (2024)

Microneedles in pain management of Cancer
od: Islam, Shafiqul
Izdano: (2022)

A review on less explored plants with anticancer activity
od: Al Nahid, Mohammed Tansen
Izdano: (2021)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Izdano: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Izdano: (2024)